Partager

By Date


  • 23-May-2023

    English

    Reviews of National Healthcare Quality

    OECD Healthcare Quality Reviews seek to examine what works and what does not work in different countries – both to benchmark the efforts of countries and to provide advice on reforms to improve their health system.

    Related Documents
  • 10-May-2023

    English

    Integrating Care to Prevent and Manage Chronic Diseases - Best Practices in Public Health

    People today are living longer with complex health needs but often receive fragmented care. This has prompted countries to support patient-centred, integrated care models. As part of OECD’s work on best practices in public health, this report outlines policy recommendations to prevent and manage chronic diseases by integrating care. Policy recommendations were drawn from a review of key integrated care models implemented in OECD and EU27 countries.
  • 20-April-2023

    English

    Private Health Insurance

    The OECD Study on Private Health Insurance was completed between 2001 and 2004, and assessed the role that private health insurance (PHI) plays in OECD member countries. This page lists all reports released as part of the study.

    Related Documents
  • 20-April-2023

    English

    Public Health Reviews

    This series of OECD Reviews of Public Health provide in-depth analysis and policy recommendations to strengthen priority areas of countries’ public health systems, highlighting best practice examples that allow learning from shared experiences, and the spreading of innovative approaches.

    Related Documents
  • 20-April-2023

    English

    Pharmaceutical Pricing Policy project

    The OECD Pharmaceutical Pricing Policy project had two main objectives: to add to the base of information about pharmaceutical pricing policy in OECD countries and develop a taxonomy and framework for making international comparisons of policies, and to analyse cross-national impacts and implications of policies, particularly with respect to the impacts on pharmaceutical prices paid in other countries and on pharmaceutical R&D.

    Related Documents
  • 20-April-2023

    English

    Healthcare prices and Purchasing Power Parities

    Variations in per capita health spending can be the result of differences in prices for healthcare goods and services, and in the quantity of care that individuals are using (“volume”). Eurostat and the OECD have calculated purchasing power parities and price level indexes for GDP and some 50 product groups, including health and hospitals, on a regular and timely basis.

    Related Documents
  • 20-April-2023

    English

    International Trade in Health Services

    Medical tourism is apparently growing rapidly and yet there is little data on the extent of the provision of health care services across borders. This OECD paper identifies the key emerging policy issues relating to the rise in this new market.

    Related Documents
  • 18-April-2023

    English

    Health at a Glance: Latin America and the Caribbean 2023

    This second edition of Health at a Glance: Latin America and the Caribbean, prepared jointly by OECD and the World Bank, presents a set of key indicators of health status, determinants of health, healthcare resources and utilisation, healthcare expenditure and financing, quality of care, health workforce, and ageing across 33 Latin America and the Caribbean countries. Each of the indicators is presented in a user-friendly format, consisting of charts illustrating variations across countries, and over time, brief descriptive analyses highlighting the major findings conveyed by the data, and a methodological box on the definition of the indicators and any limitations in data comparability. This edition of Health at a Glance: Latin America and the Caribbean also provides thematic analyses on two key topics for building more resilient health in the LAC region: the impact of the COVID-19 pandemic on LAC healthcare systems, and climate change and health.
    Also AvailableEgalement disponible(s)
  • 3-April-2023

    English

    Innovative providers’ payment models for promoting value-based health systems - Start small, prove value, and scale up

    Innovative providers’ payment models represent an important policy lever that could be used to promote value-based health systems. By bundling services across the continuum of care or to target acute events or chronic conditions, innovative payment models set financial incentives for providers to increase efficiency in service delivery, improve health outcomes and enhance patient experience with care. This paper offers insights on value-based payment models, a type of innovative payment model implemented in several OECD countries and reviews the publicly available evidence on the impact of those payment models on value. Innovative payment models tend to be exceptional and small-scale compared to activity-based payment models and have been extensively piloted in the United States while implementation and evaluation in other countries is limited. The publicly available empirical evidence points to modest efficiency and quality gains from value-based payment models. Impact on healthcare spending, outcomes and patient experience varies across programmes. Given the significant variation in the key features of value-based payment models and the context-specific issues they address, those models do not offer a one-size-fits-all solution. This paper outlines several intervention points that policy makers need to consider when designing and implementing value-based payment models to maximise their positive outcome.
  • << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10